Can vitiligo enhance immunotherapy response in melanoma?Melanoma patients who develop vitiligo during immunotherapy tend to have better outcomes. In the new IMMUNIZE-MI study, researchers at Cancer Center Amsterdam are testing whether deliberately inducing this immune response with topical MI therapy can strengthen standard immunotherapy. The study focuses primarily on safety and dose optimization, while searching for early signs of a stronger anti-tumor immune response.
Seeing the unseen: novel imaging to capture placental insufficiency as it unfoldsClinicians currently measure everything around the placenta, such as fetal growth and blood flow patterns, but not the placenta itself. In her PhD thesis, Fatimah Al Darwish combined MRI, contrast-enhanced ultrasound and photoacoustic imaging in a rat model to directly visualize placental perfusion and oxygenation as insufficiency unfolds, uncovering a critical window for early detection and therapy.
